Literature DB >> 28508227

The MDM2 promoter T309G polymorphism was associated with preeclampsia susceptibility.

Saeedeh Salimi1,2, Abbas Mohammadpour-Gharehbagh3,4, Mahnaz Rezaei1,2, Mojtaba Sajadian1,2, Batool Teimoori5, Atefeh Yazdi5, Mojgan Mokhtari5, Minoo Yaghmaei6.   

Abstract

PURPOSE: Preeclampsia (PE) is a hypertensive disorder of pregnancy in which abnormal proliferation and apoptosis of placenta trophoblast has a pivotal role in its pathophysiology. The aim of the current study was to examine the association between Mouse Double Minute 2 (MDM2) T309G and 40 bp insertion/deletion (I/D) polymorphisms and PE risk.
METHODS: A case-control study was conducted on 208 PE women and 164 healthy pregnant women matching age, sex, and ethnicity. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and PCR methods were used for genotyping.
RESULTS: The MDM2 309GG genotype was associated with PE, and this genotype was found to be a risk factor for PE. There was no association between the MDM2 I/D polymorphism and PE. The haplotype-based association analysis revealed no association between MDM2 T309G and 40 bp I/D polymorphisms and PE. The frequency of TT-DD and GG-DD combined genotypes were significantly higher in PE women with marginal P values (P = 0.046).
CONCLUSIONS: The MDM2 309GG genotype was associated with higher risk of PE. The TT-DD and GG-DD combined genotypes were higher in PE women.

Entities:  

Keywords:  Gene; MDM2; Polymorphism; Preeclampsia

Mesh:

Substances:

Year:  2017        PMID: 28508227      PMCID: PMC5476551          DOI: 10.1007/s10815-017-0941-3

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  34 in total

1.  Increased apoptosis in first trimester extravillous trophoblasts from pregnancies at higher risk of developing preeclampsia.

Authors:  Guy St J Whitley; Philip R Dash; Laura-Jo Ayling; Federico Prefumo; Baskaran Thilaganathan; Judith E Cartwright
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

Review 2.  Epidemiology of pregnancy-induced hypertension.

Authors:  J Zhang; J Zeisler; M C Hatch; G Berkowitz
Journal:  Epidemiol Rev       Date:  1997       Impact factor: 6.222

3.  Paternal and maternal components of the predisposition to preeclampsia.

Authors:  M S Esplin; M B Fausett; A Fraser; R Kerber; G Mineau; J Carrillo; M W Varner
Journal:  N Engl J Med       Date:  2001-03-22       Impact factor: 91.245

4.  MDM2 SNP309 variation confers the susceptibility to hepatocellular cancer: a meta-analysis based on 4271 subjects.

Authors:  Jinli Lv; Bo Zhu; Liang Zhang; Qichao Xie; Wenlei Zhuo
Journal:  Int J Clin Exp Med       Date:  2015-04-15

5.  CASPASE-8 gene polymorphisms (rs13416436 and rs2037815) are not associated with preeclampsia development in Brazilian women.

Authors:  Ivanir Celso Orlando; Sarah Cristina Sato Vaz Tanaka; Marly Aparecida Spadotto Balarin; Sueli Riul da Silva; Cristina Wide Pissetti
Journal:  J Matern Fetal Neonatal Med       Date:  2017-02-08

6.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

Review 7.  The p53 response to DNA damage.

Authors:  David W Meek
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

8.  Upregulation of P53 promoted G1 arrest and apoptosis in human umbilical cord vein endothelial cells from preeclampsia.

Authors:  Qinqin Gao; Xiaolin Zhu; Jie Chen; Caiping Mao; Lubo Zhang; Zhice Xu
Journal:  J Hypertens       Date:  2016-07       Impact factor: 4.844

9.  Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'.

Authors:  Tom R Gaunt; Santiago Rodríguez; Ian Nm Day
Journal:  BMC Bioinformatics       Date:  2007-11-02       Impact factor: 3.169

10.  Preeclampsia is associated with alterations in the p53-pathway in villous trophoblast.

Authors:  Andrew N Sharp; Alexander E P Heazell; Dora Baczyk; Caroline E Dunk; Helen A Lacey; Carolyn J P Jones; Jonathan E Perkins; John C P Kingdom; Philip N Baker; Ian P Crocker
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

View more
  2 in total

Review 1.  Targeting MDM2 for novel molecular therapy: Beyond oncology.

Authors:  Wei Wang; Jiang-Jiang Qin; Mehrdad Rajaei; Xin Li; Xiaoyi Yu; Courtney Hunt; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2019-10-06       Impact factor: 12.944

2.  Analysis of polymorphisms, promoter methylation, and mRNA expression profile of maternal and placental P53 and P21 genes in preeclamptic and normotensive pregnant women.

Authors:  Mahdiyeh Harati-Sadegh; Leila Kohan; Batool Teimoori; Mehrnaz Mehrabani; Saeedeh Salimi
Journal:  J Biomed Sci       Date:  2019-11-08       Impact factor: 8.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.